Prediction of recurrence after radical surgery for gastric cancer: A scoring system obtained from a prospective multicenter study

Annals of Surgery

Volumn 241, Issue 2, 2005, Pages 247-255

  Marrelli, Daniele ^a   De Stefano, Alfonso ^a   De Manzoni, Giovanni ^b   Morgagni, Paolo ^c   Leo, Alberto Di ^b   Roviello, Franco ^a,d  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c MORGAGNI PIERANTONI HOSPITAL   (Italy)

^d NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; KAPLAN MEIER METHOD; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STOMACH CANCER;

ADULT; AGED; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; STOMACH NEOPLASMS;

EID: 12744261230     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000152019.14741.97     Document Type: Article

References (37)

1. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours, 5th ed. New York: John Wiley & Sons, 1997.
2. Siewert JR, Bottcher K, Stein HJ, et al. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg. 1998;228:449-461.
3. Harrison JD, Fielding JW. Prognostic factors for gastric cancer influencing clinical practice. World J Surg. 1995;19:496-500.
4. Kim JP, Lee JH, Kim SJ, et al. Clinicopathologic characteristics and prognostic factors in 10,783 patients with gastric cancer. Gastric Cancer. 1998;1:125-133.
5. Yoo CH, Noh SH, Shin DW, et al. Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000;87:236-242.
6. Roukos DH, Lorenz M, Karakostas K, et al. Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study. Br J Cancer. 2001;84:1602-1609.
7. Folli S, Morgagni P, Roviello F, et al. Risk factors for lymph node metastases and their prognostic significance in early gastric cancer (EGC) for the Italian Research Group for Gastric Cancer (IRGGC). Jpn J Clin Oncol. 2001;31:495-499.
8. Roviello F, Marrelli D, Vindigni C, et al. p53 accumulation is a prognostic factor in intestinal-type gastric carcinoma but not in the diffuse type. Ann Surg Oncol. 1999;6:739-745.
9. Kooby DA, Suriawinata A, Klimstra DS, et al. Biologic predictors of survival in node-negative gastric cancer. Ann Surg. 2003;237:828-835.
10. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma [2nd English ed]. Gastric Cancer. 1998;1:10-24.
11. Marrelli D, Roviello F, de Manzoni G, et al. Italian Research Group for Gastric Cancer. Different patterns of recurrence in gastric cancer depending on Lauren's histological type: longitudinal study. World J Surg. 2002;26:1160-1165.
12. Hosmer DW Jr, Wang CY, Lin IC, et al. A computer program for stepwise logistic regression using maximum likelihood estimation. Comput Programs Biomed. 1978;8:121-134.
13. Vander Poorten VL, Balm AJ, Hilgers FJ, et al. The development of a prognostic score for patients with parotid carcinoma. Cancer. 1999;85:2057-2067.
14. Maehara Y, Oshiro T, Baba H, et al. Lymphatic invasion and potential for tumor growth and metastasis in patients with gastric cancer. Surgery. 1995;117:380-385.
15. Kodera Y, Yamamura Y, Torii A, et al. The prognostic value of preoperative serum levels of CEA and CA 19-9 in patients with gastric cancer. Am J Gastroenterol. 1996;91:49-53.
16. Blok P, Craanen ME, Offerhaus GJ, et al. Gastric carcinoma: clinical, pathogenic, and molecular aspects. QJM. 1997;90:735-749.
17. Inoue H, Matsuyama A, Mimori K, et al. Prognostic score of gastric cancer determined by cDNA microarray. Clin Cancer Res. 2002;8:3475-3479.
18. Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002;20:791-796.
19. Smaletz O, Scher HI, Small EJ, et al. Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration. J Clin Oncol. 2002;20:3972-3982.
20. Shiraishi N, Inomata M, Osawa N, et al. Early and late recurrence after gastrectomy for gastric carcinoma: univariate and multivariate analyses. Cancer. 2000;89:255-261.
21. Ohno S, Tomisaki S, Oiwa H, et al. Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach. J Am Coll Surg. 1995;180:577-582.
22. Pacelli F, Papa V, Caprino P, et al. Proximal compared with distal gastric cancer: multivariate analysis of prognostic factors. Am Surg. 2001;67:697-703.
23. Talamonti MS, Kim SP, Yao KA, et al. Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery. 2003;134:720-727.
24. Maehara Y, Emi Y, Tomisaki S, et al. Age-related characteristics of gastric carcinoma in young and elderly patients. Cancer. 1996;77:1774-1780.
25. Okuno K, Shigeoka H, Tanaka A, et al. Clinicopathological evaluation of T2-gastric cancer among age groups. Hepatogastroenterology. 2000;47:1180-1182.
26. De Manzoni G, Verlato G, Guglielmi A, et al. Prognostic significance of lymph node dissection in gastric cancer. Br J Surg. 1996;83:1604-1607.
27. Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999;340:908-914.
28. Roviello F, Marrelli D, Morgagni P, et al. Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study. Ann Surg Oncol. 2002;9:894-900.
29. Cuschieri A. Does chemoradiotherapy after intended curative surgery increase survival of gastric cancer patients? Gut. 2002;50:751.
30. Nishimori H, Yasoshima T, Denno R, et al. A novel experimental mouse model of peritoneal dissemination of human gastric cancer cells: different mechanisms in peritoneal dissemination and hematogenous metastasis. Jpn J Cancer Res. 2000;91:715-722.
31. Marubini E, Bonfanti G, Bozzetti F, et al. A prognostic score for patients resected for gastric cancer. Eur J Cancer. 1993;29A:845-850.
32. Victorzon M, Lundin J, Haglund C, et al. A risk score for predicting outcome in patients with gastric cancer, based on stage, sialyl-Tn immunoreactivity and ploidy: a multivariate analysis. Int J Cancer. 1996;67:190-193.
33. Kologlu M, Kama NA, Reis E, et al. A prognostic score for gastric cancer. Am J Surg. 2000;179:521-526.
34. Kattan MW, Karpeh MS, Mazumdar M, et al. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol. 2003;21:3647-3650.
35. Karpeh MS, Leon L, Klimstra D, et al. Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients. Ann Surg. 2000;232:362-371.
36. Fujimoto S, Takahashi M, Mutou T, et al. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer. 1997;79:884-891.
37. Ambiru S, Miyazaki M, Ito H, et al. Benefits and limits of hepatic resection for gastric metastases. Am J Surg. 2001;181:279-283.